Table 1 Numbers of brand-name drugs for which we can calculate the correlation between the usage rate of generic drugs and monthly personal incomes based on NODJ with p values less than 0.05
Code | Therapeutic categories of standard commodity classification number | Outpatient out-of-hospital | Outpatient in-hospital | Inpatient | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|  |  | Total (all) | Total (p < 0.05) | Negative correlation | Positive correlation | Total (all) | Total (p < 0.05) | Negative correlation | Positive correlation | Total (all) | Total (p < 0.05) | Negative correlation | Positive correlation |
112 | Hypnotics and sedative, antianxietics | 27 | 11 | 11 | 0 | 19 | 8 | 8 | 0 | 16 | 1 | 1 | 0 |
113 | Antiepileptics | 24 | 2 | 0 | 2 | 16 | 2 | 1 | 1 | 13 | 0 | 0 | 0 |
114 | Antipyretics, analgesics and anti-inflammatory agents | 10 | 2 | 2 | 0 | 8 | 1 | 1 | 0 | 2 | 0 | 0 | 0 |
116 | Antiperkinsonism agents | 20 | 2 | 2 | 0 | 7 | 1 | 1 | 0 | 8 | 2 | 1 | 1 |
117 | Psychotropic agents | 21 | 3 | 3 | 0 | 12 | 2 | 2 | 0 | 19 | 0 | 0 | 0 |
118 | Agents used for common cold | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
119 | Other agents affecting central nervous system | 7 | 6 | 6 | 0 | 4 | 4 | 4 | 0 | 2 | 0 | 0 | 0 |
121 | Local anesthetics | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
122 | Skeletal muscle relaxants | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
123 | Autonomic agents | 4 | 4 | 2 | 2 | 3 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
124 | Antispasmodics | 5 | 3 | 3 | 0 | 4 | 2 | 2 | 0 | 4 | 1 | 1 | 0 |
133 | Antimotionsickness agents | 4 | 3 | 3 | 0 | 3 | 3 | 3 | 0 | 2 | 0 | 0 | 0 |
211 | Cardiotonics | 8 | 1 | 1 | 0 | 6 | 2 | 1 | 1 | 1 | 0 | 0 | 0 |
212 | Antiarrhythmic agents | 19 | 4 | 4 | 0 | 15 | 7 | 7 | 0 | 7 | 0 | 0 | 0 |
213 | Diuretics | 16 | 6 | 6 | 0 | 10 | 2 | 2 | 0 | 8 | 1 | 1 | 0 |
214 | Antihypertensives | 29 | 18 | 16 | 2 | 21 | 3 | 3 | 0 | 9 | 2 | 0 | 2 |
216 | Vasoconstrictors | 4 | 1 | 1 | 0 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 |
217 | Vasodilators | 20 | 13 | 13 | 0 | 16 | 11 | 11 | 0 | 9 | 0 | 0 | 0 |
218 | Agents for hyperlipidemias | 19 | 13 | 12 | 1 | 15 | 10 | 9 | 1 | 5 | 0 | 0 | 0 |
219 | Other cardiovascular agents | 14 | 6 | 5 | 1 | 8 | 3 | 3 | 0 | 7 | 1 | 1 | 0 |
222 | Antitussives | 4 | 1 | 0 | 1 | 4 | 0 | 0 | 0 | 2 | 1 | 0 | 1 |
223 | Expectorants | 11 | 7 | 7 | 0 | 7 | 2 | 2 | 0 | 6 | 0 | 0 | 0 |
224 | Antitussives and expectorants | 7 | 1 | 0 | 1 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
225 | Bronchodilators | 15 | 1 | 1 | 0 | 9 | 2 | 2 | 0 | 2 | 1 | 0 | 1 |
231 | Antidiarrheals, intestinal regulators | 10 | 2 | 0 | 2 | 8 | 1 | 1 | 0 | 5 | 0 | 0 | 0 |
232 | Agents for peptic ulcer | 17 | 12 | 12 | 0 | 15 | 8 | 8 | 0 | 11 | 1 | 1 | 0 |
234 | Antacids | 9 | 3 | 2 | 1 | 7 | 3 | 1 | 2 | 3 | 1 | 1 | 0 |
235 | Purgatives and clysters | 4 | 3 | 3 | 0 | 4 | 0 | 0 | 0 | 3 | 0 | 0 | 0 |
236 | Cholagogues | 2 | 2 | 2 | 0 | 2 | 0 | 0 | 0 | 2 | 0 | 0 | 0 |
239 | Other agents affecting digestive organs | 15 | 5 | 4 | 1 | 11 | 3 | 2 | 1 | 6 | 0 | 0 | 0 |
243 | Thyroid and para-thyroid hormone preparations | 9 | 1 | 0 | 1 | 5 | 0 | 0 | 0 | 3 | 2 | 0 | 2 |
245 | Adrenal hormone preparations | 11 | 3 | 1 | 2 | 9 | 1 | 0 | 1 | 7 | 2 | 1 | 1 |
247 | Estrogen and gestagen preparations | 5 | 0 | 0 | 0 | 2 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
248 | Mixed hormone preparations | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
249 | Other hormone preparations (including antihormone preparations) | 4 | 2 | 2 | 0 | 3 | 2 | 1 | 1 | 1 | 0 | 0 | 0 |
253 | Oxytocics | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
259 | Other agents for uro-genital and anal organ | 15 | 7 | 6 | 1 | 13 | 2 | 2 | 0 | 3 | 0 | 0 | 0 |
290 | Other agents affecting individual organs | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
311 | Vitamin A, D and preparations | 8 | 7 | 7 | 0 | 5 | 2 | 2 | 0 | 0 | 0 | 0 | 0 |
312 | Vitamin B1 preparations | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
313 | Vitamin B preparations (except Vitamin B1) | 9 | 0 | 0 | 0 | 8 | 0 | 0 | 0 | 3 | 0 | 0 | 0 |
315 | Vitamin E and preparations | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
316 | Vitamin K and preparations | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
317 | Mixed vitamin preparations (except mixed vitamin preparations compounded of vitamin A and D) | 4 | 2 | 1 | 1 | 2 | 0 | 0 | 0 | 2 | 0 | 0 | 0 |
319 | Other vitamin preparations | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
321 | Calcium compounds and preparations | 5 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
322 | Mineral preparations | 4 | 2 | 0 | 2 | 3 | 0 | 0 | 0 | 4 | 1 | 0 | 1 |
323 | Saccharide preparations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
332 | Hemostatics | 5 | 2 | 2 | 0 | 3 | 0 | 0 | 0 | 2 | 0 | 0 | 0 |
333 | Anticoagulants | 3 | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 2 | 0 | 0 | 0 |
339 | Other agents relating to blood and body fluides | 13 | 10 | 10 | 0 | 13 | 5 | 5 | 0 | 9 | 0 | 0 | 0 |
391 | Agents for liver disease | 2 | 1 | 1 | 0 | 3 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
392 | Antidotes | 3 | 1 | 1 | 0 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 |
394 | Agents for treatment of gout | 11 | 3 | 3 | 0 | 5 | 1 | 1 | 0 | 2 | 0 | 0 | 0 |
396 | Antidiabetic agents | 27 | 7 | 5 | 2 | 18 | 2 | 2 | 0 | 7 | 1 | 0 | 1 |
399 | Agents affecting metabolism, n.e.c. | 29 | 7 | 5 | 2 | 15 | 4 | 3 | 1 | 11 | 1 | 0 | 1 |
422 | Antimetabolic agents | 3 | 2 | 2 | 0 | 2 | 0 | 0 | 0 | 2 | 0 | 0 | 0 |
429 | Other antitumor agents | 8 | 6 | 6 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
441 | Antihistamines | 9 | 2 | 1 | 1 | 5 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
442 | Agents for stimulation therapy | 2 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
449 | Other antiallergic agents | 21 | 9 | 7 | 2 | 16 | 0 | 0 | 0 | 5 | 0 | 0 | 0 |
520 | Chinese medicines | 1 | 0 | 0 | 0 | 11 | 0 | 0 | 0 | 8 | 1 | 1 | 0 |
590 | Other crude drug and chinese medicine formulations | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
613 | Antibiotic preparations acting mainly on gram-positive, gram-negative bacteria | 21 | 5 | 5 | 0 | 14 | 4 | 3 | 1 | 5 | 1 | 0 | 1 |
614 | Antibiotic preparations acting mainly on gram-positive bacteria and mycoplasma | 9 | 4 | 3 | 1 | 5 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
615 | Antibiotic preparations acting mainly on gram-positive, gram-negative bacteria, rickettsia and chlamydia | 3 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 2 | 0 | 0 | 0 |
616 | Antibiotic preparations acting mainly on acid-fast bacteria | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
617 | Antibiotic preparations acting mainly on mold | 3 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 2 | 1 | 0 | 1 |
621 | Sulfonamide preparations | 3 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
622 | Anti-tuberculous agents | 3 | 2 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
624 | Synthetic antibacterials | 4 | 2 | 2 | 0 | 5 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
625 | Anti-virus agents | 5 | 3 | 2 | 1 | 2 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
629 | Other chemotherapeutics | 4 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
711 | Excipients | 2 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
713 | Solvents | 2 | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 1 | 0 | 0 | 0 |
714 | Flavoring, odor improving and coloring agents | 3 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
721 | X-ray contrast agents | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
729 | Other diagnostic agents (except extracorporeal diagnostic medicines) | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
799 | Agents for not mainly purpose of therapeutic, n.e.c. | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
811 | Opium alkaloids preparations | 4 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 3 | 0 | 0 | 0 |